Sequent Scientific Limited — Important, 14-07-2025: General Updates

SeQuent Scientific's Board, following input from its Nomination and Remuneration Committee, has approved the re-appointment of Dr. Kamal Sharma and Mr. Milind Sarwate as Non-Executive Independent Directors for a second five-year term. This strengthens governance with experienced leaders. Dr. Sharma, former MD of Lupin, brings five decades of pharma expertise. Mr. Sarwate, known for his roles on boards like Asian Paints and Mahindra Finance, and past CFO/CHRO experience, also continues his valuable contribution. This awaits shareholder approval.